Recent News

• 05.13.2025 - ClearPoint Neuro Reports First Quarter 2025 Results
• 05.12.2025 - ClearPoint Neuro Announces Investment of up to $110 Million by Oberland Capital with $33.5 Million Funded at Closing
• 04.28.2025 - ClearPoint Neuro, Together with its Partner Clinical Laserthermia Systems, Announces FDA Submission to Expand the Labeling of ClearPoint Prism(R) to Include 1.5 T MRI
• 04.25.2025 - ClearPoint Neuro to Announce First Quarter 2025 Results May 13, 2025
• 04.24.2025 - ClearPoint Neuro Announces Full Market Release of ClearPoint Navigation Software Version 3.0 – Delivering the First End-to-End ClearPoint Navigation Solution to the Operating Room

Recent Filings

• 05.13.2025 - EX-99.1 EX-99.1
• 05.13.2025 - 10-Q Quarterly report [Sections 13 or 15(d)]
• 05.13.2025 - 8-K Current report
• 05.12.2025 - EX-99.1 EX-99.1
• 05.12.2025 - 8-K Current report
• 05.12.2025 - 424B5 Prospectus [Rule 424(b)(5)]
• 05.09.2025 - SCHEDULE 13G/A Statement of Beneficial Ownership by Certain Investors
• 04.09.2025 - DEF 14A Other definitive proxy statements
• 04.02.2025 - 4 Statement of changes in beneficial ownership of securities
• 04.02.2025 - 4 Statement of changes in beneficial ownership of securities